ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

EDARBI
Hypertension
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

EDARBI Rx

Generic Name and Formulations:
Azilsartan medoxomil 40mg, 80mg; tabs.

Company:
Arbor Pharmaceuticals, LLC

Therapeutic Use:

Indications for EDARBI:

Hypertension, alone or in combination with other antihypertensive agents.

Adult:

≥18yrs: Monotherapy, not volume-depleted: 80mg once daily. Volume-depleted (eg, concomitant high-dose diuretics): initially 40mg once daily.

Children:

<18yrs: not established.

Contraindications:

Concomitant aliskiren-containing products in patients with diabetes.

Warnings/Precautions:

Fetal toxicity may develop; discontinue if pregnancy is detected. Correct salt/volume depletion before starting therapy, or reduce initial dose (see Adult); monitor for hypotension. Renal impairment: monitor for worsening renal function. Severe CHF. Renal artery stenosis. Severe hepatic impairment. Neonates. Pregnancy (Cat.D); avoid. Nursing mothers: not recommended.

Interactions:

See Contraindications. Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; avoid or monitor closely. Avoid concomitant aliskiren in renal impairment (CrCl <60mL/min). May be antagonized by, and renal toxicity potentiated by NSAIDs, including selective COX-2 inhibitors (monitor renal function esp. in elderly and/or volume-depleted). May potentiate lithium; monitor.

Pharmacological Class:

Angiotensin II receptor blocker (ARB).

Adverse Reactions:

Diarrhea; orthostatic hypotension, elevated serum creatinine.

How Supplied:

Tabs—30

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs